Researchers at the University of Colorado Boulder have identified a molecule in Burmese python blood that suppresses appetite ...

OpenAI announced Thursday that it has entered into an agreement to acquire Astral, the company behind popular open source Python development tools such as uv, Ruff, and ty, and integrate the company ...

New research suggests python blood could hold the key to a new weight-loss drug, as the snake metabolite suppresses appetites in mice. It is the ...

Scientists have discovered a compound in python blood that reduces appetite and could lead to safer, more effective weight-loss drugs.

OpenAI, the leading artificial intelligence platform, has aimed to built a strong platform against Anthropic. The ChatGPT owner said on Thursday, March 20, 2026, it will acquire Python ...

OpenAI said on Thursday it will buy Python toolmaker Astral, as the ChatGPT maker seeks to strengthen its portfolio against ...

Discover how a compound from Burmese python blood helped mice curb their appetite and lose weight in a groundbreaking study.

In a move clearly designed to strengthen its position among developers, OpenAI has acquired Python tool maker Astral. The house of Altman expects the deal to strengthen the ecosystem for its Codex ...

OpenAI has acquired Astral, a startup whose essential Python development tools are used by millions. This strategic move aims ...

March 19 (Reuters) - OpenAI said on Thursday it will acquire Python toolmaker Astral, as the ChatGPT ​owner looks to ...